Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) shares saw an uptick in trading volume on Tuesday . 1,343,879 shares were traded during trading, a decline of 20% from the previous session’s volume of 1,682,243 shares.The stock last traded at $41.20 and had previously closed at $42.57. Analyst Upgrades and Downgrades A number of […]
Form PRER14A Cerevel Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Insider Sells $326,762.38 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) insider Mark Bodenrader sold 7,889 shares of the business’s stock in a transaction on Wednesday, December 20th. The stock was sold at an average price of $41.42, for a total value of $326,762.38. Following the completion of the transaction, the insider now directly owns 17,724 shares […]
Cerevel Therapeutics (NASDAQ:CERE – Free Report) had its price target decreased by Mizuho from $29.00 to $25.00 in a research report released on Monday, MarketBeat reports. Mizuho currently has a neutral rating on the biotechnology company’s stock. A number of other research analysts have also weighed in on the stock. Bank of America lowered shares […]